Recombinant GPIIb/IIIa (Abciximab Biosimilar) antibody
The Human Chimeric anti-GPIIb/IIIa (Abciximab Biosimilar) antibody (ABIN7538053) specifically detects GPIIb/IIIa (Abciximab Biosimilar) in ELISA and WB.
The antibody is reactive with Human samples.
Catalog No. ABIN7538053
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant GPIIb/IIIa (Abciximab Biosimilar) antibody (ABIN7538053)
Target
GPIIb/IIIa (Abciximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human, Mouse
Clonality
Chimeric
Conjugate
Un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Abciximab Biosimilar - Anti-ITGA2B_ITGB3 mAb - Research Grade
-
Characteristics
- Antibody Type: Fab-G1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- GPIIb/IIIa (Abciximab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Abciximab, a chimeric mouse/human monoclonal antibody, is a glycoprotein (GP) IIb/IIIa inhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein IIb/IIIa, vitronectin and Mac-1 receptors.
-
CAS-No
- 143653-53-6
Target
-
You are here:
